USD 19.49
(0.26%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 10.66 Billion | 10.84 Billion | 9.58 Billion | 8.53 Billion | 9.27 Billion | 9.25 Billion |
Cost of Revenue | 6.63 Billion | 6.92 Billion | 5.73 Billion | 4.74 Billion | 5.3 Billion | 5.32 Billion |
Gross Profit | 4.03 Billion | 3.92 Billion | 3.85 Billion | 3.78 Billion | 3.96 Billion | 3.92 Billion |
Operating Expenses | 3.2 Billion | 3.21 Billion | 2.73 Billion | 2.82 Billion | 3.12 Billion | 3.32 Billion |
Selling, General and Administrative Expenses | 2.96 Billion | 1.53 Billion | 1.29 Billion | 1.24 Billion | 1.5 Billion | 1.66 Billion |
Research and Development Expenses | 270 Million | 258 Million | 230 Million | 238 Million | 255 Million | 58 Million |
Other Expenses | -27 Million | 1.42 Billion | 1.21 Billion | 1.33 Billion | 1.36 Billion | 1.59 Billion |
Cost and Expenses | 9.63 Billion | 10.13 Billion | 8.46 Billion | 7.56 Billion | 8.43 Billion | 8.65 Billion |
Operating Income | 1.02 Billion | 708 Million | 1.11 Billion | 963 Million | 841 Million | 605 Million |
Interest Expense | 193 Million | 106 Million | 74 Million | 97 Million | 114 Million | 95 Million |
Income Tax Expense | 296 Million | 214 Million | 246 Million | 241 Million | 230 Million | 118 Million |
Earnings before Tax | 784 Million | 602 Million | 1.1 Billion | 919 Million | 785 Million | 573 Million |
Net Income | 442 Million | 352 Million | 829 Million | 630 Million | 539 Million | 6.67 Billion |
Earnings Per Share Basic | 2.61 | 0.67 | 1.49 | 1.10 | 0.81 | 9.82 |
Earnings Per Share Diluted | 2.58 | 0.67 | 1.49 | 1.09 | 0.81 | 9.78 |
Weighted Average Shares Outstanding | 169.34 Million | 524.2 Million | 554.87 Million | 574.27 Million | 639.22 Million | 679.73 Million |
Weighted Average Shares Outstanding (Diluted) | 171.33 Million | 525.94 Million | 557.62 Million | 576.3 Million | 641.53 Million | 682.66 Million |
Gross Margin | 0.38 | 0.36 | 0.40 | 0.44 | 0.43 | 0.42 |
EBIT Margin | 0.12 | 0.10 | 0.16 | 0.16 | 0.14 | 0.10 |
Profit Margin | 0.04 | 0.03 | 0.09 | 0.07 | 0.06 | 0.72 |
EBITDA | 1.32 Billion | 1.07 Billion | 1.53 Billion | 1.22 Billion | 1.25 Billion | 854 Million |
Earnings Before Tax Margin | 0.10 | 0.07 | 0.12 | 0.11 | 0.09 | 0.07 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 2.78 Billion | 2.64 Billion | 10.66 Billion | 2.52 Billion | 2.74 Billion | 2.74 Billion |
Cost of Revenue | 1.64 Billion | 1.55 Billion | 6.63 Billion | 1.5 Billion | 1.61 Billion | 1.63 Billion |
Gross Profit | 1.14 Billion | 1.08 Billion | 4.03 Billion | 1.02 Billion | 1.12 Billion | 1.1 Billion |
Operating Expenses | 872 Million | 826 Million | 2.95 Billion | 831 Million | 768 Million | 827 Million |
Selling, General and Administrative Expenses | 872 Million | 825 Million | - | 831 Million | 815 Million | 823 Million |
Research and Development Expenses | - | - | - | 270 Million | - | - |
Other Expenses | 6 Million | - | - | - | - | - |
Cost and Expenses | 2.51 Billion | 2.37 Billion | 9.59 Billion | 2.33 Billion | 2.38 Billion | 2.46 Billion |
Operating Income | 269 Million | 261 Million | 1.07 Billion | 193 Million | 354 Million | 279 Million |
Interest Expense | 47 Million | 16 Million | 193 Million | 42 Million | 68 Million | 45 Million |
Income Tax Expense | 53 Million | 57 Million | 296 Million | 49 Million | 96 Million | 106 Million |
Earnings before Tax | 239 Million | 252 Million | 757 Million | 93 Million | 294 Million | 239 Million |
Net Income | 177 Million | 181 Million | 442 Million | 41 Million | 189 Million | 118 Million |
Earnings Per Share Basic | 0.35 | 0.35 | - | 0.08 | 0.37 | 0.23 |
Earnings Per Share Diluted | 0.34 | 0.35 | - | 0.08 | 0.37 | 0.23 |
Weighted Average Shares Outstanding | 512.1 Million | 511.85 Million | 511.77 Million | 511.8 Million | 511.85 Million | 511.85 Million |
Weighted Average Shares Outstanding (Diluted) | 515.53 Million | 511.85 Million | 514.06 Million | 511.8 Million | 515.5 Million | 511.85 Million |
Gross Margin | 0.41 | 0.41 | 0.38 | 0.40 | 0.41 | 0.40 |
EBIT Margin | 0.13 | 0.14 | - | 0.11 | 0.16 | 0.13 |
Profit Margin | 0.06 | 0.07 | 0.04 | 0.02 | 0.07 | 0.04 |
EBITDA | 361 Million | 357 Million | - | 286 Million | 451 Million | 367 Million |
Earnings Before Tax Margin | 0.10 | 0.10 | 0.10 | 0.08 | 0.13 | 0.10 |
PUR
JAGSNPHARM
G1A
JLT
GGP
NXC